Loading...
Market
Will the glaucoma treatment and retina implant be commercially available in the US by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Press releases from the manufacturing company and major medical news outlets
Story
Study Shows First-of-Its-Kind Glaucoma Treatment and Retina Implant Improves Reading Ability in 38 Blind Participants
Oct 29, 2024, 11:50 AM
Recent research has demonstrated promising advancements in vision restoration for individuals with severe vision loss. A study involving 38 participants who were legally blind showed that a tiny chip, functioning as a replacement retina, was successfully implanted. Preliminary results indicated a significant enhancement in the participants' ability to read an eye exam scale. This innovative approach marks a potential breakthrough in glaucoma treatment, with the first-of-its-kind therapy now being utilized in Massachusetts. Researchers noted that this is the first instance of restoring the ability to read fluently among blind patients, highlighting the significance of these findings in the field of ophthalmology.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Successful full-eye transplant with vision restoration • 25%
Partial vision restoration in transplanted eyes • 25%
No significant advancements • 25%
Other significant advancements • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Accelerated Approval • 25%
Full Approval • 25%
Conditional Approval • 25%
No Approval • 25%